Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

164 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HIV-Related Atherosclerosis: State-of-the-Art-Review.
Avagimyan A, Pogosova N, Kakturskiy L, Sheibani M, Urazova O, Trofimenko A, Navarsdyan G, Jndoyan Z, Abgaryan K, Fogacci F, Galli M, Agati L, Kobalava Z, Shafie D, Marzilli M, Gogiashvili L, Sarrafzadegan N. Avagimyan A, et al. Among authors: agati l. Curr Probl Cardiol. 2023 Sep;48(9):101783. doi: 10.1016/j.cpcardiol.2023.101783. Epub 2023 May 11. Curr Probl Cardiol. 2023. PMID: 37172874 Review.
Diabetic Cardiomyopathy: 2023 Update by the International Multidisciplinary Board of Experts.
Avagimyan A, Fogacci F, Pogosova N, Kakrurskiy L, Kogan E, Urazova O, Kobalava Z, Mikhaleva L, Vandysheva R, Zarina G, Trofimenko A, Navasardyan G, Mkrtchyan L, Galli M, Jndoyan Z, Aznauryan A, Saahakyan K, Agati L, Shafie D, Cicero A, Salvo GD, Sarrafzadegan N. Avagimyan A, et al. Among authors: agati l. Curr Probl Cardiol. 2024 Jan;49(1 Pt A):102052. doi: 10.1016/j.cpcardiol.2023.102052. Epub 2023 Aug 26. Curr Probl Cardiol. 2024. PMID: 37640176 Review.
Methotrexate & rheumatoid arthritis associated atherosclerosis: A narrative review of multidisciplinary approach for risk modification by the international board of experts.
Avagimyan A, Fogacci F, Pogosova N, Kakturskiy L, Jndoyan Z, Faggiano A, Bairamyan T, Agati L, Sattar Y, Mkrchyan L, Avetisyan G, Ginosyan K, Aznauryan A, Sahakyan K, Trofimenko A, Urazova O, Mikhaleva L, Vandysheva R, Kogan E, Demura T, Kc M, Shafie D, Nicola S, Brussino L, Cicero A, Biondi-Zoccai G, Sarrafzadegan N. Avagimyan A, et al. Among authors: agati l. Curr Probl Cardiol. 2024 Feb;49(2):102230. doi: 10.1016/j.cpcardiol.2023.102230. Epub 2023 Nov 29. Curr Probl Cardiol. 2024. PMID: 38040221 Review.
Rivaroxaban for Patients with Intermittent Claudication.
Ramacciotti E, Volpiani GG, Britto KF, Agati LB, Ribeiro CM, Aguiar VCR, Paganotti A, Pereira FM, Caffaro RA, Krakauer R, Rached HRS, Fareed J, Wolosker N, Anand SS, Eikelboom JW, Chang C, Lopes RD. Ramacciotti E, et al. Among authors: agati lb. NEJM Evid. 2024 Sep;3(9):EVIDoa2400021. doi: 10.1056/EVIDoa2400021. Epub 2024 Aug 26. NEJM Evid. 2024. PMID: 39185955 Clinical Trial.
Arrhythmic Mitral Valve Prolapse Phenotype: An Unsupervised Machine Learning Analysis Using a Multicenter Cardiac MRI Registry.
Akyea RK, Figliozzi S, Lopes PM, Bauer KB, Moura-Ferreira S, Tondi L, Mushtaq S, Censi S, Pavon AG, Bassi I, Galian-Gay L, Teske AJ, Biondi F, Filomena D, Stylianidis V, Torlasco C, Muraru D, Monney P, Quattrocchi G, Maestrini V, Agati L, Monti L, Pedrotti P, Vandenberk B, Squeri A, Lombardi M, Ferreira AM, Schwitter J, Aquaro GD, Pontone G, Chiribiri A, Rodríguez Palomares JF, Yilmaz A, Andreini D, Florian AR, Francone M, Leiner T, Abecasis J, Badano LP, Bogaert J, Georgiopoulos G, Masci PG. Akyea RK, et al. Among authors: agati l. Radiol Cardiothorac Imaging. 2024 Jun;6(3):e230247. doi: 10.1148/ryct.230247. Radiol Cardiothorac Imaging. 2024. PMID: 38900026 Free PMC article.
The outcome of genetic and non-genetic pediatric cardiomyopathies.
AlAlakhfash A, Agati L, Mazzesi G, Elhobi D, Alqwaiee A, Alhory K, Almesned A, Alhasnan Z, Alwadai A. AlAlakhfash A, et al. Among authors: agati l. Egypt Heart J. 2024 Apr 3;76(1):43. doi: 10.1186/s43044-024-00473-7. Egypt Heart J. 2024. PMID: 38568384 Free PMC article.
Cost-effectiveness analysis of extended thromboprophylaxis with rivaroxaban versus no prophylaxis in high-risk patients after hospitalisation for COVID-19: an economic modelling study.
Carvalho de Oliveira CC, Agati LB, Ribeiro CM, Resende Aguiar VC, Caffaro RA, da Silva Santos M, Alves Fernandes RR, Alberto da Silva Magliano C, Tafur A, Spyropoulos AC, Lopes RD, Fareed J, Ramacciotti E. Carvalho de Oliveira CC, et al. Among authors: agati lb. Lancet Reg Health Am. 2023 Aug;24:100543. doi: 10.1016/j.lana.2023.100543. Epub 2023 Jun 23. Lancet Reg Health Am. 2023. PMID: 37366432 Free PMC article.
164 results